Fantin R, Schmid B, Busche C, Fritz H, Fink K, Busch H-J
Universitäts-Notfallzentrum, Universitätsklinikum Freiburg, Sir-Hans-A.-Krebsstraße, 79106, Freiburg, Deutschland.
Anästhesie, Intensiv- und Schmerztherapie, Krankenhaus Halle, Halle, Deutschland.
Med Klin Intensivmed Notfmed. 2018 Nov;113(8):658-663. doi: 10.1007/s00063-017-0338-1. Epub 2017 Aug 25.
During the last decade target temperature management has become an integral part of postresuscitation care. Within recent years there was a strong debate about the optimal target temperature, which might have effects on the preclinical induction of hypothermia. The present investigation focuses on the use of mild therapeutic hypothermia by emergency services in the state of Baden-Württemberg (Germany) and compares it to results of a prior study in 2008.
Between April and August 2014 a questionnaire was sent to all senior emergency physicians of emergency services in Baden Württemberg. The survey period was April to August of 2014. Parts of the questionnaire were similar to a previous one in 2008, to ensure comparability to the former data; other parts were added to set new focuses. The data were analyzed in anonymized form.
The response rate was 72.4% (97/134). Of the 97 sites which responded to the questionnaire significantly more use preclinical hypothermia, compared to 2008 (72.2% [70/97] vs. 41.7%); 62.9% (44/70) declare cooling resuscitated patients routinely (vs. 17.7% in 2008). Cold infusions (85.7%), icepacks (64.3%), passive cooling (37.1%), nasal cooling (2.9%) and cooling caps (1.4%) are used (multiple naming was possible). Sites that did not use mild therapeutic hypothermia stated the following reasons: lack of equipment, short transport time and missing data for the intervention. Four sites reported on complications with therapeutic hypothermia.
The present investigation shows an increased use of preclinical cooling after cardiopulmonary resuscitation as compared to 2008. Therefore, recent discussions concerning the optimal target temperature in postresuscitation care did not result in a waiving of preclinical therapeutic strategies in Baden-Württemberg. The emergency services sites/locations estimated the complication rates of mild therapeutic hypothermia as very low. Lack of equipment seems to be the main reason to refuse the preclinical use of therapeutic hypothermia. In conclusion, preclinical mild therapeutic hypothermia has become an integral part in the standard care of resuscitated patients in Baden-Württemberg.
在过去十年中,目标温度管理已成为心肺复苏后护理的一个组成部分。近年来,关于最佳目标温度存在激烈争论,这可能会对临床前低温诱导产生影响。本研究聚焦于德国巴登-符腾堡州紧急医疗服务中轻度治疗性低温的应用,并将其与2008年的一项先前研究结果进行比较。
2014年4月至8月,向巴登-符腾堡州所有紧急医疗服务的高级急诊医生发送了一份问卷。调查期为2014年4月至8月。问卷的部分内容与2008年的前一份问卷相似,以确保与以前的数据具有可比性;其他部分是新增的,以设定新的重点。数据以匿名形式进行分析。
回复率为72.4%(97/134)。在回复问卷的97个机构中,与2008年相比,临床前低温的使用显著增加(72.2%[70/97]对41.7%);62.9%(44/70)的机构宣称常规对复苏患者进行降温(2008年为17.7%)。使用的方法有冷输液(85.7%)、冰袋(64.3%)、被动降温(37.1%)、鼻腔降温(2.9%)和降温帽(1.4%)(可多选)。未使用轻度治疗性低温的机构给出了以下原因:设备不足、运输时间短和缺乏干预数据。有四个机构报告了治疗性低温的并发症。
本研究表明,与2008年相比,心肺复苏后临床前降温的使用有所增加。因此,近期关于心肺复苏后护理中最佳目标温度的讨论并未导致巴登-符腾堡州放弃临床前治疗策略。紧急医疗服务机构估计轻度治疗性低温的并发症发生率非常低。设备不足似乎是拒绝临床前使用治疗性低温的主要原因。总之,临床前轻度治疗性低温已成为巴登-符腾堡州复苏患者标准护理的一个组成部分。